[Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs]
- PMID: 17209432
[Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs]
Abstract
Small interfering RNAs (siRNA) provide a powerful approach for sequence-specific silencing of gene expression. In the present study we investigated inhibition of c-myc gene expression by siRNAs targeted to the sequence 1452-1470 b. in third exon of c-myc mRNA and to homologous regions in second exons of c-myc (697-715 b.) and N-myc (302-320 b.) mRNAs. siRNAs were prepared enzymatically according to the scheme, including dsDNA-templates preparation using Klenow fragment, separate in vitro transcription of each RNA strand with subsequent hybridization and removal of leader sequences by T1 RNase. Investigation of c-myc gene silencing by siRNAs revealed that enzymatically prepared siRNAs induce stronger inhibition of c-myc expression, than siRNA with the same sequence prepared by chemical synthesis. It was found that down-regulation of c-myc gene expression by investigated siRNAs results in efficient inhibition and even complete arrest of carcinoma cell proliferation, moreover, the extend of growth inhibition correlates with the level of siRNA-mediated reduction of c-myc mRNA.
Similar articles
-
Silencing of c-myc expression in tumor cells by siRNA.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(6-7):867-72. doi: 10.1081/NCN-200026033. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15560074
-
Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA.Oligonucleotides. 2006 Spring;16(1):15-25. doi: 10.1089/oli.2006.16.15. Oligonucleotides. 2006. PMID: 16584292
-
Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs.FEBS Lett. 2004 Feb 27;560(1-3):210-4. doi: 10.1016/S0014-5793(04)00113-9. FEBS Lett. 2004. PMID: 14988024
-
Cancer therapeutics: targeting the dark side of Myc.Eur J Cancer. 2005 Nov;41(16):2485-501. doi: 10.1016/j.ejca.2005.08.017. Epub 2005 Oct 20. Eur J Cancer. 2005. PMID: 16243519 Review.
-
Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.Semin Oncol. 2006 Aug;33(4):498-512. doi: 10.1053/j.seminoncol.2006.04.012. Semin Oncol. 2006. PMID: 16890804 Review.
Cited by
-
Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.Signal Transduct Target Ther. 2023 Sep 6;8(1):335. doi: 10.1038/s41392-023-01589-z. Signal Transduct Target Ther. 2023. PMID: 37669923 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources